MyFinsight
Home
Blog
About
Accounts receivable, net
$211,656K
(50.29%↑ Y/Y)
Marketable securities
$192,114K
(-49.16%↓ Y/Y)
Cash and cash
equivalents
$179,953K
(24.35%↑ Y/Y)
Inventories, net
$83,924K
(90.64%↑ Y/Y)
Prepaid expenses and
other current assets
$55,849K
(77.77%↑ Y/Y)
Total current assets
$723,496K
(-2.08%↓ Y/Y)
Intangible assets, net
$469,459K
(-2.46%↓ Y/Y)
Goodwill
$119,431K
(2.06%↑ Y/Y)
Other assets
$55,015K
(96.74%↑ Y/Y)
Deferred income tax
assets, net
$49,061K
(693.74%↑ Y/Y)
Property and equipment,
net
$10,197K
(-7.88%↓ Y/Y)
Restricted cash
$1,450K
Total assets
$1,428,109K
(3.31%↑ Y/Y)
Total liabilities and
stockholders' equity
$1,428,109K
(3.31%↑ Y/Y)
Total stockholders'
equity
$1,031,226K
(-3.07%↓ Y/Y)
Total liabilities
$396,883K
(24.61%↑ Y/Y)
Accumulated other
comprehensive loss, net of tax
-$138K
(31.00%↑ Y/Y)
Additional paid-in capital
$574,094K
(15.52%↑ Y/Y)
Retained earnings
$457,212K
(-19.38%↓ Y/Y)
Total current
liabilities
$347,378K
(21.31%↑ Y/Y)
Operating lease
liabilities, long-term
$29,427K
(20.69%↑ Y/Y)
Other liabilities
$19,872K
(156.02%↑ Y/Y)
Contingent consideration,
long-term
$206K
Common stock, 0.001 par
value 130,000,000...
$58K
(3.57%↑ Y/Y)
Accrued product returns
and rebates
$198,844K
(9.91%↑ Y/Y)
Accounts payable and
accrued liabilities
$108,458K
(39.52%↑ Y/Y)
Other current
liabilities
$40,076K
(44.65%↑ Y/Y)
Back
Back
Balance Sheet
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
source: myfinsight.com